CN114384172A - Emamectin benzoate purity detection method - Google Patents

Emamectin benzoate purity detection method Download PDF

Info

Publication number
CN114384172A
CN114384172A CN202111546475.7A CN202111546475A CN114384172A CN 114384172 A CN114384172 A CN 114384172A CN 202111546475 A CN202111546475 A CN 202111546475A CN 114384172 A CN114384172 A CN 114384172A
Authority
CN
China
Prior art keywords
emamectin benzoate
flow rate
solution
impurities
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202111546475.7A
Other languages
Chinese (zh)
Inventor
薛树会
任建海
罗俊峰
刘文耀
杨程程
于晓军
周士珂
徐亚会
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
QILU SYNVA PHARMACEUTICAL CO Ltd
Original Assignee
QILU SYNVA PHARMACEUTICAL CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by QILU SYNVA PHARMACEUTICAL CO Ltd filed Critical QILU SYNVA PHARMACEUTICAL CO Ltd
Priority to CN202111546475.7A priority Critical patent/CN114384172A/en
Publication of CN114384172A publication Critical patent/CN114384172A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography

Landscapes

  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)

Abstract

A method for detecting the purity of emamectin benzoate comprises the following steps: the method comprises the following steps: weighing 100mg of emamectin benzoate sample, dissolving the emamectin benzoate sample in methanol, and putting the solution into a 100ml volumetric flask for constant volume to obtain 1mg/ml emamectin benzoate solution; step two: sending the emamectin benzoate solution obtained in the step one into a liquid chromatograph for spectrum analysis, wherein the conditions of the liquid chromatograph are as follows: a chromatographic column: chromatographic column with octadecylsilane chemically bonded silica as filler; mobile phase: acetonitrile: ammonium acetate solution at a concentration of 0.1% ═ 58: 42; flow rate: gradient flow rate elution; detection wavelength: 244 nm; column temperature: 40 ℃; sample introduction amount: 10 μ l. The invention can efficiently separate the emamectin benzoate from the impurities through liquid phase detection, has high impurity separation degree, can effectively identify 17 impurities, can better and accurately know the quality of the emamectin benzoate product so as to control the quality and safety of the product, and can improve the problems existing in the process flow through the types and the amount of the impurities so as to reduce the impurities in the product and improve the product quality.

Description

Emamectin benzoate purity detection method
Technical Field
The invention belongs to the field of emamectin benzoate detection, and particularly relates to an emamectin benzoate purity detection method.
Background
The emamectin benzoate is used as a pesticide raw material, and the existing detection method is used for effectively identifying 17 kinds of impurities, has high impurity separation identification degree and better controls the quality and safety of products.
Disclosure of Invention
The invention provides a method for detecting the purity of emamectin benzoate, which is used for overcoming the defects in the prior art.
The invention is realized by the following technical scheme:
a method for detecting the purity of emamectin benzoate comprises the following steps:
the method comprises the following steps: weighing 100mg of emamectin benzoate sample, dissolving the emamectin benzoate sample in methanol, and putting the solution into a 100ml volumetric flask for constant volume to obtain 1mg/ml emamectin benzoate solution;
step two: sending the emamectin benzoate solution obtained in the step one into a liquid chromatograph for spectrum analysis, wherein the conditions of the liquid chromatograph are as follows: a chromatographic column: chromatographic column with octadecylsilane chemically bonded silica as filler; mobile phase: acetonitrile: ammonium acetate solution at a concentration of 0.1% ═ 58: 42; flow rate: gradient flow rate elution; detection wavelength: 244 nm; column temperature: 40 ℃; sample introduction amount: 10 μ l.
In the above method for detecting the purity of emamectin benzoate, the methanol in the first step is chromatographically pure methanol.
In the above method for detecting the purity of emamectin benzoate, the acetonitrile in the second step is chromatographically pure acetonitrile.
In the above method for detecting the purity of emamectin benzoate, the gradient flow rate in the second step is as follows: the flow rate is 1.2ml/min for 0-25min, 1.7ml/min for 25-58min, and 1.2ml/min for 58-60 min.
The invention has the advantages that: the invention can efficiently separate the emamectin benzoate from the impurities through liquid phase detection, has high impurity separation degree, can effectively identify 17 impurities, can better and accurately know the quality of the emamectin benzoate product so as to control the quality and safety of the product, and can improve the problems existing in the process flow through the types and the amount of the impurities so as to reduce the impurities in the product and improve the product quality.
Drawings
In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings needed to be used in the description of the embodiments or the prior art will be briefly introduced below, and it is obvious that the drawings in the following description are some embodiments of the present invention, and for those skilled in the art, other drawings can be obtained according to these drawings without creative efforts.
FIG. 1 is one of the liquid chromatograms obtained in the present invention;
FIG. 2 is a second liquid chromatogram obtained according to the present invention;
FIG. 3 is a third liquid chromatogram obtained in the present invention.
Detailed Description
In order to make the objects, technical solutions and advantages of the embodiments of the present invention clearer, the technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the drawings in the embodiments of the present invention, and it is obvious that the described embodiments are some, but not all, embodiments of the present invention. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
A method for detecting the purity of emamectin benzoate comprises the following steps:
the method comprises the following steps: weighing 100mg of emamectin benzoate sample, dissolving the emamectin benzoate sample in methanol, and putting the solution into a 100ml volumetric flask for constant volume to obtain 1mg/ml emamectin benzoate solution;
step two: sending the emamectin benzoate solution obtained in the step one into a liquid chromatograph for spectrum analysis, wherein the conditions of the liquid chromatograph are as follows: a chromatographic column: chromatographic column with octadecylsilane chemically bonded silica as filler; mobile phase: acetonitrile: ammonium acetate solution at a concentration of 0.1% ═ 58: 42; flow rate: gradient flow rate elution; detection wavelength: 244 nm; column temperature: 40 ℃; sample introduction amount: 10 μ l.
Preferably, the methanol in the first step is chromatographically pure methanol.
Preferably, the acetonitrile in the second step is chromatographically pure acetonitrile.
Preferably, the flow rate of the gradient flow rate elution in the second step is as follows: the flow rate is 1.2ml/min for 0-25min, 1.7ml/min for 25-58min, and 1.2ml/min for 58-60 min.
As can be seen from FIGS. 1-3, the liquid chromatography detection method of the application can effectively and efficiently separate the main peaks and the impurity peaks of the emamectin benzoate to obtain the accurate purity of the emamectin benzoate, and the impurity peaks are well separated to facilitate the analysis of the substances of the impurities, so that the corresponding standard peaks can be obtained, more detailed product information can be provided for customers, problems which may occur in each batch of production operation can be judged according to the types of the impurities, and the problems can be improved in the subsequent operation to improve the quality of the subsequent products.
Finally, it should be noted that: the above examples are only intended to illustrate the technical solution of the present invention, but not to limit it; although the present invention has been described in detail with reference to the foregoing embodiments, it will be understood by those of ordinary skill in the art that: the technical solutions described in the foregoing embodiments may still be modified, or some technical features may be equivalently replaced; and such modifications or substitutions do not depart from the spirit and scope of the corresponding technical solutions of the embodiments of the present invention.

Claims (4)

1. A emamectin benzoate purity detection method is characterized by comprising the following steps: the method comprises the following steps:
the method comprises the following steps: weighing 100mg of emamectin benzoate sample, dissolving the emamectin benzoate sample in methanol, and putting the solution into a 100ml volumetric flask for constant volume to obtain 1mg/ml emamectin benzoate solution;
step two: sending the emamectin benzoate solution obtained in the step one into a liquid chromatograph for spectrum analysis, wherein the conditions of the liquid chromatograph are as follows: a chromatographic column: chromatographic column with octadecylsilane chemically bonded silica as filler; mobile phase: acetonitrile: ammonium acetate solution at a concentration of 0.1% ═ 58: 42; flow rate: gradient flow rate elution; detection wavelength: 244 nm; column temperature: 40 ℃; sample introduction amount: 10 μ l.
2. The emamectin benzoate purity detection method according to claim 1, which is characterized in that: the methanol in the step one is chromatographic pure methanol.
3. The emamectin benzoate purity detection method according to claim 1, which is characterized in that: and the acetonitrile in the second step is chromatographic pure acetonitrile.
4. The emamectin benzoate purity detection method according to claim 1, which is characterized in that: the flow rate of gradient flow rate elution in the second step is as follows: the flow rate is 1.2ml/min for 0-25min, 1.7ml/min for 25-58min, and 1.2ml/min for 58-60 min.
CN202111546475.7A 2021-12-16 2021-12-16 Emamectin benzoate purity detection method Pending CN114384172A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202111546475.7A CN114384172A (en) 2021-12-16 2021-12-16 Emamectin benzoate purity detection method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202111546475.7A CN114384172A (en) 2021-12-16 2021-12-16 Emamectin benzoate purity detection method

Publications (1)

Publication Number Publication Date
CN114384172A true CN114384172A (en) 2022-04-22

Family

ID=81197052

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202111546475.7A Pending CN114384172A (en) 2021-12-16 2021-12-16 Emamectin benzoate purity detection method

Country Status (1)

Country Link
CN (1) CN114384172A (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113341038A (en) * 2021-05-14 2021-09-03 河北威远生物化工有限公司 Method for measuring content of emamectin benzoate

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113341038A (en) * 2021-05-14 2021-09-03 河北威远生物化工有限公司 Method for measuring content of emamectin benzoate

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
AIYALU RAJASEKARAN 等: "Analysis of Emamectin Benzoate Residues in Cauliflower using HPLC", 《RESEARCH J. PHARM. AND TECH.》, vol. 6, no. 10, pages 1157 - 1160 *
张健希: "液相色谱-串联质谱法检测仙草中甲氨基阿维菌素苯甲酸盐的残留", 《质量安全与检验检测》, vol. 30, no. 4, pages 2 *
梁振益 等: "反相液相色谱法测定甲氨基阿维菌素苯甲酸盐的含量", 《海南大学学报(自然科学版)》, vol. 24, no. 2, pages 115 - 118 *
毕富春 等: "高效液相色谱法定量分析甲氨基阿维菌素苯甲酸盐", 《农药科学与管理》, vol. 24, no. 3, pages 3 - 2 *

Similar Documents

Publication Publication Date Title
Gomis et al. Simultaneous determination of fat-soluble vitamins and provitamins in milk by microcolumn liquid chromatography
Needham et al. Optimized stationary phases for the high-performance liquid chromatography–electrospray ionization mass spectrometric analysis of basic pharmaceuticals
van Deursen et al. Possibilities and limitations of fast temperature programming as a route towards fast GC
Boutegrabet et al. Determination of stilbene derivatives in Burgundy red wines by ultra-high-pressure liquid chromatography
Cruz et al. Application of gas-diffusion microextraction to the analysis of free and bound acetaldehyde in wines by HPLC–UV and characterization of the extracted compounds by MS/MS detection
US20160252516A1 (en) System and method for high throughput mass spectrometric analysis of proteome samples
Yoshida et al. High‐speed analyses using rapid resolution liquid chromatography on 1.8‐μm porous particles
CN111141850B (en) Liquid phase detection separation method for related substances of acetaminophen bulk drug
CN114384172A (en) Emamectin benzoate purity detection method
Hyötyläinen et al. Analysis of pesticides in red wines by on-line coupled reversed-phase liquid chromatography–gas chromatography with vaporiser/precolumn solvent split/gas discharge interface
EP3801810A1 (en) High resolution and semi-preparative recycling chromatography system for isolation and preparation of unknown trace impurities in pharmaceutical products
Henneberg et al. High-performance gas chromatograph—mass spectrometer interfacing: investigation and optimization of flow and temperature
Szpunar-Łobińska et al. Interferences in ultratrace speciation of organolead and organotin by gas chromatography with atomic spectrometric detection
Dubbelman et al. Systematic evaluation of commercially available ultra-high performance liquid chromatography columns for drug metabolite profiling: optimization of chromatographic peak capacity
CN114354801B (en) Analysis method for contents of three aminopyridine isomers in (R) -3-Boc-aminopiperidine
Vaňková et al. Effect of gradient steepness on the kinetic performance limits and peak compression for reversed-phase gradient separations of small molecules
CN114062518B (en) Method for separating and measuring content of tartaric acid optical isomer
CN111239278B (en) Method for detecting recombinant human interleukin-12 protein charge variant and application
Layton et al. UPLC Separation for the analysis of cannabinoid content in cannabis flowers and extracts
US9267927B2 (en) Robust and low backpressure on-column tunneled frit for nano-UPLC-MS applications
CN115575540B (en) Method for detecting light stabilizer 2020 by adopting ultra-efficient synthetic phase chromatography-mass spectrometry
Chen et al. Determination of nine ginsenosides in health foods by solid extraction phase-ultra performance liquid chromatography-tandem mass spectrometry
EP3454060B1 (en) Analysis method and use of an analysis device for obtaining the recovery rate of a substance to be measured
Chen et al. Separation of β-receptor blockers and analogs by Capillary Liquid Chromatography (CLC) and Pressurized Capillary Electrochromatography (pCEC) using a vancomycin chiral stationary phase column
CN111220716A (en) Method for measuring optical purity of levetiracetam intermediate

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination